The Use of Hyaluronic Acid in the Treatment of Ocular Hypotonia
An ocular hypotensive syndrome may result from chronically recurring uveitis and it may lead to a considerable reduction of vision. Under certain conditions the intraocular pressure may be raised for several months in these cases by intraocular injections of Healon®. These conditions, as defined after analysis of a case observed by us, are a pathological increase in outflow resistance of the trabecular system and a reduction, though not arrest, of the production of aqueous humour (Körner et al. 1985, 1986).
KeywordsHyaluronic Acid Intraocular Pressure Anterior Chamber Outflow Resistance Retinal Edema
Unable to display preview. Download preview PDF.
- Hultsch E, Balazs EA (1975) Transport of hyaluronic acid from vitreous: mechanism and dynamics. Annual Meeting of the Association for Research and Ophthalmology (Arvo), p 2Google Scholar
- Moses RA (1975) Intraocular pressure. In: Moses RA (ed.) Adler’s Physiology of the Eye. Clinical Application, 6th ed. Mosby, St. Louis, pp 179-209Google Scholar
- Schubert H, Denlinger JL, Balazs EA (1981) Na-Hyaluronate injected into the anterior chamber of the owl monkey: effect on IOP and rate of disappearance. Invest Ophthalmol Vis Sci (Suppl) 20: 118Google Scholar